tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Decibel Therapeutics appoints Matthew Kapusta to board of directors

Decibel Therapeutics (DBTX) announced the appointment of Matthew Kapusta to its Board of Directors. Matthew Kapusta has 25 years of experience in the life sciences industry and currently serves as Chief Executive Officer and Director of uniQure (QURE), a global gene therapy company.

Elevate Your Investing Strategy:

Published first on TheFly

See today’s best-performing stocks on TipRanks >>

Read More on DBTX:

Disclaimer & DisclosureReport an Issue

1